CardioGenics Holdings Inc

Equities

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:59:49 2024-02-01 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	CardioGenics Holdings Inc. Announces License Agreement	CI
2015	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI

CardioGenics Holdings Inc. Appoints Karim Murabet as Director

January 12, 2015 at 04:42 pm EST

On January 12, 2015 the board of directors of CardioGenics Holdings Inc. appointed Karim Murabet as a director of the company. Mr. Murabet will serve as an independent director of the company. Mr. Murabet currently resides in the United Arab Emirates and is a Partner and Director responsible for business development and public relations in ICap Group FZC.

Latest news about CardioGenics Holdings Inc

CardioGenics Holdings Inc. Announces License Agreement	21-09-03	CI
CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	15-11-01	CI
CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	15-10-04	CI
CardioGenics Holdings Inc. Appoints Karim Murabet as Director	15-01-12	CI
CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	13-09-27	CI
CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	13-08-21	CI
CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	13-06-05	CI
CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	13-06-03	CI
CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	13-05-31	CI
CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	13-02-28	CI
CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	13-02-26	CI
CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	12-04-17	CI
CardioGenics Holdings Inc will Change its Ticker to CGNH.E from CGNH	12-03-22	CI
CardioGenics Holdings Inc Announces Earnings Results for the Year Ended October 31, 2011	12-01-31	CI
CardioGenics Holdings Inc Auditor Raises 'Going Concern' Doubt	12-01-30	CI

Chart CardioGenics Holdings Inc

Duration

Period

More charts

Company Profile

CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
CARDIOGENICS HOLDINGS INC	-.--%	142
BIOMÉRIEUX	-0.60%	12.62B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.67B
DIASORIN S.P.A.	+1.82%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-51.89%	3.22B
ANDON HEALTH CO., LTD.	+6.42%	2.59B
VITROLIFE AB	-14.59%	2.05B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B
MYRIAD GENETICS, INC.	+1.67%	1.76B

Diagnostic & Testing Substances